Study Suggests Stem Cell Treatment May Lead to MS Remission

The results of a recent clinical trial show that transplanting a person’s own stem cells back into them, after high-dose immunosuppressive therapy, can cause long-term remission of multiple sclerosis. Multiple sclerosis (MS) is a disease in which the nervous system is attacked by the immune system. In the study 69% of the patients had lived for 5 years with no remission of MS symptoms, brain lesions or progression of the disease. The patients had not been given any multiple sclerosis medicines during this time.

The clinical trial was funded by the National Institute of Allergy and Infectious Diseases. The three year results were published in 2014 and the five year results were published this month.

The findings of the trials suggest that this treatment is more effective than other MS medicines have shown to be. The next step will be to develop a larger trial to directly compare this treatment path to other MS medicines.

The symptoms experienced by people suffering from MS can include fatigue, chronic pain, weakness and motor and speech difficulties. Over time the symptoms can get progressively worse as the disease develops.

The clinical trial used volunteer sufferers of multiple sclerosis from the ages of 26 to 52 years old. These patients had been taking available MS drugs but were still experiencing a worsening in their conditions.

A doctor that has extensive experience in handling patients with MS is Dr. Shiva Gopal Vasishta. Dr. Shiva Gopal Vasishta earned his degree in medicine and psychiatry in 1979 from the Government Medical College in India. His residency was performed at Boston City Hospital.

Dr. Shiva Gopal Vasishta has a practice at Eastern Neurodiagnostic Associates where he treats patients with brain disorders, including multiple sclerosis. In order to help his older patients, Dr. Shiva Gopal Vasishta does accept Medicare.